No greater risk of bleeding seen in new anti-clotting drugs
Intended for healthcare professionals
Journal scan Previous     Next

No greater risk of bleeding seen in new anti-clotting drugs

New anti-clotting drugs do not present a greater risk of major bleeding than existing ones, a study suggests.

Nursing Standard. 32, 11, 17-17. doi: 10.7748/ns.32.11.17.s16

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more